What's in Millennium Pharmaceuticals, Inc.'s pipeline?

Millennium Pharmaceuticals, Inc. has 25 drugs in our index: 1 marketed, 0 filed, 3 in Phase 3, 6 in Phase 2, 15 in Phase 1.

Which companies overlap with Millennium Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Pfizer, Betta Pharmaceuticals Co., Ltd., Hoffmann-La Roche, Genentech, Inc., Grupo de Investigación Clínica en Oncología Radioterapia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/millennium-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Millennium Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Millennium Pharmaceuticals, Inc. pipeline: 1 marketed, 0 filed, 3 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 3 Phase 3 6 Phase 2 15 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Oral cholera vaccine	Oral cholera vaccine	marketed
TAK-788	TAK-788	phase 3	EGFR tyrosine kinase inhibitor	EGFR exon 20 insertion mutations	Oncology
VELCADE Administered by subcutaneous injection	VELCADE Administered by subcutaneous injection	phase 3	Proteasome inhibitor	Proteasome	Oncology
VELCADE Administered by intravenous infusion	VELCADE Administered by intravenous infusion	phase 3	Proteasome inhibitor	26S proteasome	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 2 shared drug classes
Betta Pharmaceuticals Co., Ltd. · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Genentech, Inc. · 1 shared drug class
Grupo de Investigación Clínica en Oncología Radioterapia · 1 shared drug class
Hangzhou ACEA Pharmaceutical Research Co., Ltd. · 1 shared drug class
European Myeloma Network B.V. · 1 shared drug class
Beijing InnoCare Pharma Tech Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Millennium Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Millennium Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/millennium-pharmaceuticals-inc. Accessed 2026-06-10.